New developments in the immunosuppressive drug monitoring of cyclosporine, tacrolimus, and azathioprine (Q32139680)

6 July 2017

1 reference

title

New developments in the immunosuppressive drug monitoring of cyclosporine, tacrolimus, and azathioprine (English)

1 reference

6 July 2017

0 references

1 reference

Armstrong VW

1

1 reference

6 July 2017

Oellerich M

series ordinal

2

1 reference

6 July 2017

publication date

1 February 2001

1 reference

6 July 2017

published in

Clinical Biochemistry

1 reference

6 July 2017

volume

34

1 reference

6 July 2017

issue

1

1 reference

6 July 2017

page(s)

9-16

1 reference

A BLINDED, LONG-TERM, RANDOMIZED MULTICENTER STUDY OF MYCOPHENOLATE MOFETIL IN CADAVERIC RENAL TRANSPLANTATION

6 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900175-2

Improved graft survival after renal transplantation in the United States, 1988 to 1996

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900175-2

The use of therapeutic drug monitoring to optimise immunosuppressive therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900175-2

Lake Louise Consensus Conference on cyclosporin monitoring in organ transplantation: report of the consensus panel.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900175-2

Challenges in cyclosporine therapy: the role of therapeutic monitoring by area under the curve monitoring.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900175-2

Pharmacokinetics and tolerability of a microemulsion formulation of cyclosporine in renal allograft recipients--a concentration-controlled comparison with the commercial formulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900175-2

Substitution of conventional cyclosporin with a new microemulsion formulation in renal transplant patients: results after 1 year

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900175-2

Cyclosporine microemulsion increases drug exposure and reduces acute rejection without incremental toxicity in de novo renal transplantation. International Sandimmun Neoral Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900175-2

Peak cyclosporine levels (Cmax) correlate with freedom from liver graft rejection: results of a prospective, randomized comparison of neoral and sandimmune for liver transplantation (NOF-8)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900175-2

KIDNEY FUNCTION AFTER 1:1 CONVERSION TO THE CYCLOSPORINE MICROEMULSION FORMULATION IN CHILDREN WITH LIVER ALLOGRAFTS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900175-2

Optimization of cyclosporine therapy with new therapeutic drug monitoring strategies: report from the International Neoral TDM Advisory Consensus Meeting (Vancouver, November 1997).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900175-2

Neoral monitoring by simplified sparse sampling area under the concentration-time curve: its relationship to acute rejection and cyclosporine nephrotoxicity early after kidney transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900175-2

Comparison of neoral dose monitoring with cyclosporine through levels versus 2-hr postdose levels in stable liver transplant patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900175-2

Clinical benefit of neoral dose monitoring with cyclosporine 2-hr post-dose levels compared with trough levels in stable heart transplant patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900175-2

The temporal profile of calcineurin inhibition by cyclosporine in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900175-2

A specific method for the measurement of tacrolimus in human whole blood by liquid chromatography/tandem mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900175-2

Measurement of tacrolimus (FK506) and its metabolites: a review of assay development and application in therapeutic drug monitoring and pharmacokinetic studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900175-2

Tacrolimus metabolite cross-reactivity in different tacrolimus assays.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900175-2

Role of immunophilins in therapeutic drug monitoring of immunosuppressive drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900175-2

Analysis of whole blood tacrolimus concentrations in liver transplant patients exhibiting impaired liver function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900175-2

An open-label, concentration-ranging trial of FK506 in primary kidney transplantation: a report of the United States Multicenter FK506 Kidney Transplant Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900175-2

Relationship of FK506 whole blood concentrations and efficacy and toxicity after liver and kidney transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900175-2

Tacrolimus and mycophenolate mofetil in clinical liver transplantation: experience with a steroid-sparing concept

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900175-2

Therapeutic drug monitoring of cyclosporine and tacrolimus. Update on Lake Louise Consensus Conference on cyclosporin and tacrolimus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900175-2

Azathioprine-induced myelosuppression in thiopurine methyltransferase deficient heart transplant recipient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900175-2

Should 6-thioguanine nucleotides be monitored in heart transplant recipients given azathioprine?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900175-2

Identification of thiopurine methyltransferase (TPMT) polymorphisms cannot predict myelosuppression in systemic lupus erythematosus patients taking azathioprine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900175-2

Human erythrocyte thiopurine methyltransferase: radiochemical microassay and biochemical properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900175-2

Thiopurine S-methyltransferase activity in human erythrocytes: a new HPLC method using 6-thioguanine as substrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900175-2

Inhibition of thiopurine S-methyltransferase activity by impurities in commercially available substrates: a factor for differing results of TPMT measurements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900175-2

Azathioprine-induced severe pancytopenia due to a homozygous two-point mutation of the thiopurine methyltransferase gene in a patient with juvenile HLA-B27-associated spondylarthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900175-2

Monitoring of azathioprine-induced immunosuppression with thiopurine methyltransferase activity in kidney transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900175-2

Thiopurine methyltransferase activity and its relationship to the occurrence of rejection episodes in paediatric renal transplant recipients treated with azathioprine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900175-2

High-performance liquid chromatographic assay of human red blood cell thiopurine methyltransferase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900175-2

High-performance liquid chromatographic determination of thiopurine metabolites of azathioprine in biological fluids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900175-2

Monitored high-dose azathioprine treatment reduces acute rejection episodes after renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900175-2

Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900175-2

Consensus document: therapeutic monitoring of tacrolimus (FK-506).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900175-2

10.1016/S0009-9120(00)00175-2

7 January 2021

Identifiers

DOI

1 reference

6 July 2017

1 reference